Back to Market Feed

ANAGRELIDE HCL 0.5 MG CAPSULE

anagrelide
$0.7265per EA

Strength

.5 mg/1

NDC

13668045301

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA209151

On Market Since

6/30/2017

Pharmacological Classes

Decreased Platelet Production
Phosphodiesterase 3 Inhibitors
Platelet-reducing Agent

Price History

1W

0.0%

1M

-0.5%

3M

+0.1%

6M

+1.7%

1Y

-2.3%

3Y

+1.5%

5Y

+2.8%

All

+9.4%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

CILOSTAZOL 50 MG TABLET
Generic
00093206506•Teva Pharmaceuticals USA Inc.
$0.1162
per EA
CILOSTAZOL 50 MG TABLET
Generic
50268017615•AvPAK
$0.1162
per EA
CILOSTAZOL 50 MG TABLET
Generic
60505252101•Apotex Corp.
$0.1162
per EA
CILOSTAZOL 50 MG TABLET
Generic
70436015606•Slate Run Pharmaceuticals LLC
$0.1162
per EA
CILOSTAZOL 100 MG TABLET
Generic
00093206406•Teva Pharmaceuticals USA Inc.
$0.1287
per EA
CILOSTAZOL 100 MG TABLET
Generic
00093206450•Teva Pharmaceuticals USA Inc.
$0.1287
per EA
CILOSTAZOL 100 MG TABLET
Generic
50268017715•AvPAK
$0.1287
per EA
CILOSTAZOL 100 MG TABLET
Generic
60505252201•Apotex Corp.
$0.1287
per EA
CILOSTAZOL 100 MG TABLET
Generic
70436015706•Slate Run Pharmaceuticals LLC
$0.1287
per EA
ANAGRELIDE HCL 0.5 MG CAPSULE
Generic
62135031212•Chartwell RX LLC
$0.7265
per EA